Withdrawal Statement
The authors have withdrawn their manuscript owing to incorrect handling of multiple measures in the survival analyses. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Competing Interest Statement
JRCG has stock options in Compass Therapeutics, Alloy Therapeutics and Anixa Biosciences; receives consulting fees from Anixa Biosciences and Alloy Therapeutics; and has a sponsored research agreement with Anixa Biosciences; all outside the scope of this work. LCP has research funding from the Bristol Myers Squibb for multiple myeloma research (outside the scope of this research). LCP, JRCG, KLT, SST and BLF received funding from the NIH, State of Florida, and/or US Department of Defense related to various research aspects of ovarian cancer. All other authors have no conflicts of interest to declare.
Funding Statement
This work was supported in part by the National Cancer Institute at the National Institutes of Health (grant numbers UM1 CA186107, U01 CA176726, R01 CA258679, R01 CA279065, and P01 CA87969), the James and Esther King Biomedical Research Program of the Florida Department of Health (grant number 9JK02), and the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30 CA076292). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Florida Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Boards of the Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health Institutional Review Board of Brigham and Women's Hospital, Boston, Massachusetts Institutional Review Board of Dartmouth College, Hanover, New Hampshire
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
